Related Experiment Videos
Drug binding by reservoirs in elastomeric infusion devices
1Baxter Healthcare Corporation William B. Graham Science Center Round Lake, Il 60073.
Pharmaceutical Research
|July 1, 1994
Summary
Elastomeric infusion device reservoirs show minimal drug binding. Most common intravenous drugs, when in saline or dextrose, are not significantly adsorbed by these reservoirs, ensuring treatment efficacy.
Area of Science:
- Pharmaceutical Science
- Drug Delivery Systems
- Materials Science
Background:
- Elastomeric infusion devices are widely used for continuous drug delivery.
- Potential drug-reservoir interactions can impact therapeutic efficacy.
- Quantifying drug binding is crucial for ensuring accurate dosing.
Purpose of the Study:
- To evaluate the drug binding capacity of elastomeric infusion device reservoirs.
- To determine if commonly infused drugs interact with reservoir materials.
- To establish a predictive model for drug-reservoir binding.
Main Methods:
- Assessed binding of 15 model solutes using equilibrium binding constants.
- Developed a binding model by regressing octanol/water and hexane/water partition coefficients.
- Determined partition coefficients for 17 common drugs in 0.9% Saline and 5% Dextrose formulations.
Main Results:
- The binding model successfully predicted solute binding.
- Most drugs exhibited very low octanol/formulation and hexane/formulation partition coefficients.
- Significant binding was not observed for the majority of tested drugs, with minimal loss (<2%) for fluconazole.
Conclusions:
- Elastomeric infusion device reservoirs are essentially inert regarding drug binding for the evaluated drugs.
- The study supports the use of these reservoirs without significant concern for drug adsorption.
- Accurate drug delivery is maintained as drug binding is negligible.